CDNA — CareDx, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1217234 ·
Last close
$74.56
Market Cap
$3.92B
52W High
$90.87
52W Low
$15.22
ADV30
1,302,465
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 139,362,000 | 99,075,000 | 8,112,000 | 19,292,000 | 641,457,000 | 250,480,000 | 174,001,000 |
| Jun 2026 | 131,948,000 | 96,982,000 | 257,000 | 110,636,000 | 532,988,000 | 373,636,000 | 107,390,000 |
| Mar 2026 | 117,700,000 | 84,071,000 | 1,798,000 | 2,809,000 | 411,062,000 | 77,923,000 | 97,527,000 |
| Dec 2025 | 108,386,000 | 72,874,000 | -6,040,000 | -4,108,000 | 413,228,000 | 65,429,000 | 110,127,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$93,658,000
Investing CF
$269,081,000
Financing CF
$-57,349,000
CapEx
$-9,628,000
Dividends Paid
—
Buybacks
$-87,768,000
EPS Diluted TTM
$2.07
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-505,446,000
Inventory
$6,982,000
Receivables
$34,377,000
ST Investments
$0
EBIT TTM
$-4,231,000
Pretax Income TTM
$115,192,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$497,396,000
EBITDA
$21,923,000
Free Cash Flow
$106,707,376
Enterprise Value
$4,362,600,960
Total Cash
$250,480,000
Total Debt
$20,316,000
Shares Out
52,542,786
Trailing EPS
$2.37
Book Value
$8.91
ROE
33.0%
ROA
0.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 379,805,000 | -25,071,000 | -21,354,000 | 413,228,000 | 110,127,000 | 303,101,000 | 42,032,000 |
| Dec 2024 | 333,785,000 | -55,535,000 | 52,549,000 | 491,050,000 | 112,617,000 | 378,433,000 | 38,048,000 |
| Dec 2023 | 280,324,000 | -107,063,000 | -190,284,000 | 466,826,000 | 205,498,000 | 261,328,000 | -18,388,000 |
| Dec 2022 | 321,793,000 | -77,231,000 | -76,613,000 | 542,991,000 | 112,080,000 | 430,911,000 | -25,239,000 |
TTM Snapshot
Revenues TTM
$458,089,000
NetIncome TTM
$111,012,000
OpCashFlow TTM
—
Assets (Latest)
$532,988,000
Forward EPS
$1.51
Max Pain — expiry 2026-12-18
max pain strike: $85.00 · spot: $74.44 · call oi: 797 · put oi: 4,965
Expected Move to 2026-12-18:
±$10.35
(13.90%) —
implied range
$64.09 –
$84.79
· ATM straddle on $75.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | $3.97B | $17.55 | — |
| BLLN | BillionToOne, Inc. | $4.22B | $97.50 | — |
| ACHC | Acadia Healthcare Company, Inc. | $3.53B | $37.94 | — |
| SGRY | Surgery Partners, Inc. | $3.51B | $26.85 | — |
| SHC | Sotera Health Co | $4.58B | $16.05 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Analysts Think CareDx (CDNA) Could Surge 28.09%: Read This Before Placing a Bet
2026-11-17 13:55 · Yahoo
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-06 21:05 · Yahoo
CareDx (CDNA) Upgraded to Strong Buy: Here's What You Should Know
2026-11-06 16:00 · Yahoo
CareDx Q3 Earnings Call Highlights Raised '26 Outlook & Testing Growth
2026-11-03 17:51 · Yahoo
CareDx Announces Third KOAR Analysis Published in Transplantation
2026-11-03 12:05 · Yahoo
CareDx (CDNA) Stock Still Looks Reasonable Following Its Huge 3 Year Run
2026-10-31 14:15 · Yahoo
CareDx (CDNA) Q3 2026 Earnings Call Transcript
2026-10-30 14:29 · Yahoo
CareDx, Inc Q3 2026 Earnings Call Summary
2026-10-30 12:30 · Yahoo
What CareDx (CDNA) Said on Its Q3 Earnings Call
2026-10-30 00:14 · Yahoo
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates
2026-10-29 22:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.